MODERN ASPECTS OF PATHOGENESIS AND TREATMENT OF CHOLELITHIAS
In recent years the concept of cholelithiasis pathogenesis returned to the idea of interaction by infectious and metabolic factors. As new genetic marker for evaluating of cholelithiasis risk identified and investigated variants of ATP transporters in the liver. The leading treatment method of symptomatic cholelithiasis and complicated, is considered to be laparoscopic cholecystectomy. Optimal drug to dissolve gallstones in patients with asymptomatic cholelithiasis and reduce inflammation in the gallbladder in patients with symptomatic gallstone disease is ursodeoxycholic acid.